liraglutide a glp 1 FDA Approves Generic Version of Injection, GLP-1 for Weight Loss There's still no generic Ozempic,

Even when the main compound patent expires, generic competitors must navigate a growing web of patents, making litigation and the delay of any market entry almost inevitable

For example, FDA-approved semaglutide products typically begin at 0 } Why Patients Consider Lower Doses Interest in microdosing GLP-1 usually centers around three practical concerns

This includes malnutrition, cyclical vomiting, and gastroparesis, gastroenteritis, intestinal obstruction/blockage, ileus, esophageal and bowel injury, DVT and associated pulmonary embolism, gallbladder problems necessitating surgery, and intraoperative aspiration

Even though, uh, were trying to lose weight here, patients still need to have adequate, well-rounded nutrition, so things like hair loss and hair growth arent affected, right

Last reviewed: May 16, 2026 Last updated: May 16, 2026 Written by: Jay Hastings , CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

One theoretical advantage of the GLP-1 approach is that it modulates rather than suppresses the immune system